Linked Life Data

6812979

Source:http://linkedlifedata.com/resource/pubmed/id/6812979

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5 Pt 2
pubmed:dateCreated
1982-12-16
pubmed:abstractText
Recent data from the medical literature and other sources were used in an analysis of the cost-effectiveness of coronary artery bypass graft surgery (CABG) in symptomatic patients. Health effectiveness was expressed as the gain in quality-adjusted life expectancy, allowing for a range of subjective weights attached to symptomatic benefits. Costs included those of surgery, medical management of angina, and treatment of future myocardial infarctions. CABG appears to increase unadjusted life expectancy by 0.6 years in patients with two-vessel disease and 6.9 years in patients with left main coronary disease. Even in one-vessel disease, a gain in quality-adjusted life expectancy is estimated, owing to symptomatic benefits. For patients with severe angina, the estimated net cost per quality-adjusted year of life gained from CABG ranges from $3800 in left main disease to $30,000 in one-vessel disease. These figures compare favorably with those for other accepted medical therapies, such as treatment of moderate diastolic hypertension.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0009-7322
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
III56-66
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Cost-effectiveness of coronary artery bypass surgery.
pubmed:publicationType
Journal Article, Comparative Study